Boxer Capital
Overview
Boxer Capital is a San Diego-based biotechnology investment firm, founded in 2005 as the life sciences investment arm of Tavistock Group, that invests in public and private companies across the entire drug development lifecycle.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Revolution Medicines | Jul 2019 | Series C | Lead |
| Treeline Biosciences | Apr 2021 | Series A | Co-investor |
| ELVN-ELVN | Jan 2022 | Series B | Co-investor |
| ARVION | Nov 2023 | Private Placement | Co-investor |
| Day One Biopharmaceuticals | Feb 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Norman Z.
Senior Vice President
Danny Effinger
Director Of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Boxer Capital based?
Boxer Capital is headquartered in San Diego, California, United States.
When was Boxer Capital founded?
Boxer Capital was founded in 2005.
How many portfolio companies does Boxer Capital have?
Boxer Capital has 26 portfolio companies in Caplight's dataset.
What are some companies in Boxer Capital's portfolio?
Portfolio companies visible on Caplight include Revolution Medicines, Treeline Biosciences, ELVN-ELVN, ARVION, Day One Biopharmaceuticals.
What was Boxer Capital's most recent investment shown here?
Boxer Capital's most recent investment in this portfolio sample was in ARVION in 2023.
What sectors does Boxer Capital focus on?
Boxer Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Boxer Capital focus on?
Boxer Capital typically invests at the Mid stage.
What is Boxer Capital's AUM?
Boxer Capital's assets under management are estimated between $1.0B and $10.0B.